Patents by Inventor Shobanbabu Bommagani

Shobanbabu Bommagani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tempo-cellulose structures and related methods
    Patent number: 11981756
    Abstract: In one aspect, TEMPO-cellulose structures and method of making the same are described herein. Briefly, a method of synthesizing TEMPO-cellulose comprises disposing cellulose in an aqueous medium, disposing first and second oxidizing agents in the aqueous medium and oxidizing hydroxyl groups of the cellulose via the first and second oxidizing agents in the presence of a 2,2,6,6-tetramethylpiperidine 1-oxyl radical (TEMPO) catalyst.
    Type: Grant
    Filed: July 30, 2018
    Date of Patent: May 14, 2024
    Assignee: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
    Inventors: John P. Moore, II, Jamie Hestekin, Peter Crooks, Narsimha Reddy Penthala, Shobanbabu Bommagani, Soma Shekar Dachavaram
  • TEMPO-CELLULOSE STRUCTURES AND RELATED METHODS
    Publication number: 20200199256
    Abstract: In one aspect, TEMPO-cellulose structures and method of making the same are described herein. Briefly, a method of synthesizing TEMPO-cellulose comprises disposing cellulose in an aqueous medium, disposing first and second oxidizing agents in the aqueous medium and oxidizing hydroxyl groups of the cellulose via the first and second oxidizing agents in the presence of a 2,2,6,6-tetramethylpiperidine 1-oxyl radical (TEMPO) catalyst.
    Type: Application
    Filed: July 30, 2018
    Publication date: June 25, 2020
    Inventors: John P. MOORE, Jamie HESTEKIN, Peter CROOKS, Narsimha Reddy PENTHALA, Shobanbabu BOMMAGANI, Soma Shekar DACHAVARAM
  • Melampomagnolide B dimers
    Patent number: 10118935
    Abstract: The present disclosure provides dimers of melampomagnolide B (MMB), including carbamate, carbonate, succinic amide, ester and carboxamide dimers of MMB. These derivatives are useful for treating cancer in humans, in particular in treating leukemia, including acute myelogenous leukemia (AML).
    Type: Grant
    Filed: April 19, 2018
    Date of Patent: November 6, 2018
    Assignees: BioVentures, LLC, The Regents of the University of Colorado
    Inventors: Venumadhav Janganati, Peter Crooks, Narsimha Reddy Penthala, Craig Jordan, Shobanbabu Bommagani, Jessica Ponder
  • MELAMPOMAGNOLIDE B DIMERS
    Publication number: 20180237458
    Abstract: The present disclosure provides dimers of melampomagnolide B (MMB), including carbamate, carbonate, succinic amide, ester and carboxamide dimers of MMB. These derivatives are useful for treating cancer in humans, in particular in treating leukemia, including acute myelogenous leukemia (AML).
    Type: Application
    Filed: April 19, 2018
    Publication date: August 23, 2018
    Inventors: Venumadhav Janganati, Peter Crooks, Narsimha Reddy Penthala, Craig Jordan, Shobanbabu Bommagani, Jessica Ponder
  • Melampomagnolide B dimers
    Patent number: 9981990
    Abstract: The present disclosure provides dimers of melampomagnolide B (MMB), including carbamate, carbonate, succinic amide, ester and carboxamide dimers of MMB. These derivatives are useful for treating cancer in humans, in particular in treating leukemia, including acute myelogenous leukemia (AML). A compound comprising Formula (1) wherein: Z is independently selected from the group consisting of CH2, O, C(O), and CH, wherein when Z is CH, Z is connected to Y via a double bond and Y is N.
    Type: Grant
    Filed: December 3, 2015
    Date of Patent: May 29, 2018
    Assignees: BIOVENTURES, LLC, THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
    Inventors: Venumadhav Janganati, Peter Crooks, Narsimha Reddy Penthala, Craig Jordan, Shobanbabu Bommagani, Jessica Ponder
  • Melampomagnolide B derivatives
    Patent number: 9920063
    Abstract: The present disclosure provides derivatives of melampomagnolide B (MMB), including carbonates, carbamates, thiocarbamates, ester and amide derivatives of MMB. These derivatives are useful for treating cancer in humans.
    Type: Grant
    Filed: August 30, 2016
    Date of Patent: March 20, 2018
    Assignees: BIOVENTURES, LLC, THE REGENTS OF THE UNIVERSITY OF COLORADO
    Inventors: Shobanbabu Bommagani, Peter Crooks, Narsimha Reddy Penthala, Venumadhav Janganati, Craig T. Jordan, Jessica Ponder
  • MELAMPOMAGNOLIDE B DIMERS
    Publication number: 20170362254
    Abstract: The present disclosure provides dimers of melampomagnolide B (MMB), including carbamate, carbonate, succinic amide, ester and carboxamide dimers of MMB. These derivatives are useful for treating cancer in humans, in particular in treating leukemia, including acute myelogenous leukemia (AML). A compound comprising Formula (1) wherein: Z is independently selected from the group consisting of CH2, O, C(O), and CH, wherein when Z is CH, Z is connected to Y via a double bond and Y is N.
    Type: Application
    Filed: December 3, 2015
    Publication date: December 21, 2017
    Inventors: Venumadhav Janganati, Peter Crooks, Narsimha Reddy Penthala, Craig Jordan, Shobanbabu Bommagani, Jessica Ponder
  • MELAMPOMAGNOLIDE B DERIVATIVES
    Publication number: 20160368928
    Abstract: The present disclosure provides derivatives of melampomagnolide B (MMB), including carbonates, carbamates, thiocarbamates, ester and amide derivatives of MMB. These derivatives are useful for treating cancer in humans.
    Type: Application
    Filed: August 30, 2016
    Publication date: December 22, 2016
    Inventors: Shobanbabu Bommagani, Peter Crooks, Narsimha Reddy Penthala, Venumadhav Janganati, Craig T. Jordan, Jessica Ponder
  • Melampomagnolide B derivatives
    Patent number: 9487536
    Abstract: The present disclosure provides derivatives of melampomagnolide B (MMB), including carbonates, carbamates, thiocarbamates, ester and amide derivatives of MMB. These derivatives are useful for treating cancer in humans.
    Type: Grant
    Filed: April 1, 2015
    Date of Patent: November 8, 2016
    Assignees: BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS, REGENTS OF THE UNIVERSITY OF COLORADO
    Inventors: Shobanbabu Bommagani, Peter Crooks, Narsimha Reddy Penthala, Venumadhav Janganati, Craig T. Jordan, Jessica Ponder
  • MELAMPOMAGNOLIDE B DERIVATIVES
    Publication number: 20150203508
    Abstract: The present disclosure provides derivatives of melampomagnolide B (MMB), including carbonates, carbamates, thiocarbamates, ester and amide derivatives of MMB. These derivatives are useful for treating cancer in humans.
    Type: Application
    Filed: April 1, 2015
    Publication date: July 23, 2015
    Inventors: Shobanbabu Bommagani, Peter Crooks, Narsimha Reddy Penthala, Venumadhav Janganati, Craig T. Jordan, Jessica Ponder